Cargando…

Principal component analysis of flow-volume curves in COPDGene to link spirometry with phenotypes of COPD

BACKGROUND: Parameters from maximal expiratory flow-volume curves (MEFVC) have been linked to CT-based parameters of COPD. However, the association between MEFVC shape and phenotypes like emphysema, small airways disease (SAD) and bronchial wall thickening (BWT) has not been investigated. RESEARCH Q...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verstraete, Kenneth, Das, Nilakash, Gyselinck, Iwein, Topalovic, Marko, Troosters, Thierry, Crapo, James D., Silverman, Edwin K., Make, Barry J., Regan, Elizabeth A., Jensen, Robert, De Vos, Maarten, Janssens, Wim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854102/ https://www.ncbi.nlm.nih.gov/pubmed/36658542 http://dx.doi.org/10.1186/s12931-023-02318-4

Ejemplares similares

Estimating individual treatment effects on COPD exacerbations by causal machine learning on randomised controlled trials
por: Verstraete, Kenneth, et al.
Publicado: (2023)

Validation of a method to assess emphysema severity by spirometry in the COPDGene study
por: Occhipinti, Mariaelena, et al.
Publicado: (2020)

Area under the forced expiratory flow-volume loop in spirometry indicates severe hyperinflation in COPD patients
por: Das, Nilakash, et al.
Publicado: (2019)

Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene
por: Wan, Emily S, et al.
Publicado: (2014)

Clinical and computed tomographic predictors of chronic bronchitis in COPD: a cross sectional analysis of the COPDGene study
por: Kim, Victor, et al.
Publicado: (2014)

Predicting total lung capacity from spirometry: a machine learning approach
por: Beverin, Luka, et al.
Publicado: (2023)

Artificial intelligence based software facilitates spirometry quality control in asthma and COPD clinical trials
por: Topole, Eva, et al.
Publicado: (2023)

Remdesivir, on the road to DisCoVeRy
por: Gyselinck, Iwein, et al.
Publicado: (2022)

Rationale for azithromycin in COVID-19: an overview of existing evidence
por: Gyselinck, Iwein, et al.
Publicado: (2021)

Erratum: Longitudinal Phenotypes and Mortality in Preserved Ratio Impaired Spirometry in the COPDGene Study
Publicado: (2023)

CT-based Visual Classification of Emphysema: Association with Mortality in the COPDGene Study
por: Lynch, David A., et al.
Publicado: (2018)

Impact of self-reported Gastroesophageal reflux disease in subjects from COPDGene cohort
por: Martinez, Carlos H, et al.
Publicado: (2014)

Association of thrombocytosis with COPD morbidity: the SPIROMICS and COPDGene cohorts
por: Fawzy, Ashraf, et al.
Publicado: (2018)

Chronic Obstructive Pulmonary Disease Exacerbations: Do All Roads Lead to Rome?
por: Ramakrishnan, Sanjay, et al.
Publicado: (2022)

Unexpected improvements of lung function in chronic obstructive pulmonary disease
por: Topalovic, Marko, et al.
Publicado: (2016)

Returning incidentally discovered Hepatitis C RNA-seq results to COPDGene study participants
por: Silverman, Edwin K., et al.
Publicado: (2023)

Childhood asthma is associated with COPD and known asthma variants in COPDGene: a genome-wide association study
por: Hayden, Lystra P., et al.
Publicado: (2018)

Childhood pneumonia increases risk for chronic obstructive pulmonary disease: the COPDGene study
por: Hayden, Lystra P., et al.
Publicado: (2015)

Relationship between diffusion capacity and small airway abnormality in COPDGene
por: Criner, Rachel N., et al.
Publicado: (2019)

Relative contributions of family history and a polygenic risk score on COPD and related outcomes: COPDGene and ECLIPSE studies
por: Moll, Matthew, et al.
Publicado: (2020)

Risk factors for COPD exacerbations in inhaled medication users: the COPDGene study biannual longitudinal follow-up prospective cohort
por: Busch, Robert, et al.
Publicado: (2016)

Airways resistance and specific conductance for the diagnosis of obstructive airways diseases
por: Topalovic, Marko, et al.
Publicado: (2015)

Non-linear parameters of specific resistance loops to characterise obstructive airways diseases
por: Topalovic, Marko, et al.
Publicado: (2017)

Hemizygous Deletion on Chromosome 3p26.1 Is Associated with Heavy Smoking among African American Subjects in the COPDGene Study
por: Begum, Ferdouse, et al.
Publicado: (2016)

Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trial
por: Gyselinck, Iwein, et al.
Publicado: (2021)

Correction to: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trial
por: Gyselinck, Iwein, et al.
Publicado: (2021)

Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin versus placebo – a post-hoc analysis of the BACE randomized controlled trial
por: Vermeersch, Kristina, et al.
Publicado: (2019)

Increased mortality associated with frequent exacerbations in COPD patients with mild-to-moderate lung function impairment, and smokers with normal spirometry
por: Fortis, Spyridon, et al.
Publicado: (2021)

The clinical features of the overlap between COPD and asthma
por: Hardin, Megan, et al.
Publicado: (2011)

“Mild” COPD: What Spirometry Conceals!
por: O’Donnell, Denis E.
Publicado: (2017)

Lung volumes differentiate the predominance of emphysema versus airway disease phenotype in early COPD: an observational study of the COPDGene cohort
por: Zeng, Siyang, et al.
Publicado: (2023)

Collaboration between explainable artificial intelligence and pulmonologists improves the accuracy of pulmonary function test interpretation
por: Das, Nilakash, et al.
Publicado: (2023)

Accuracy of consumer-based activity trackers as measuring tool and coaching device in patients with COPD and healthy controls
por: Blondeel, Astrid, et al.
Publicado: (2020)

Machine learning to differentiate pulmonary hypertension due to left heart disease from pulmonary arterial hypertension
por: Swinnen, Katleen, et al.
Publicado: (2023)

Co-Morbidity Patterns Identified Using Latent Class Analysis of Medications Predict All-Cause Mortality Independent of Other Known Risk Factors: The COPDGene(®) Study
por: Li, Yisha, et al.
Publicado: (2020)

Patients’ acceptance of outcome and experience measurements during hospitalisation for COPD exacerbations: a CICERO Clinical Research Collaboration–European Lung Foundation online patient survey
por: Gyselinck, Iwein, et al.
Publicado: (2023)

Machine learning for screening of at-risk, mild and moderate COPD patients at risk of FEV(1) decline: results from COPDGene and SPIROMICS
por: Wang, Jennifer M., et al.
Publicado: (2023)

Airway wall thickness is increased in COPD patients with bronchodilator responsiveness
por: Kim, Victor, et al.
Publicado: (2014)

Longitudinal Assessment of Multimorbidity Medication Patterns among Smokers in the COPDGene Cohort
por: Li, Yisha, et al.
Publicado: (2023)

Brain Activations to Dyspnea in Patients With COPD
por: Reijnders, Thomas, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v6lcb01odptu9t8hsvm3ieeafv